Kava Blocks 4-(Methylnitrosamino)-1-(3-pyridyl)-1-Butanone–Induced Lung Tumorigenesis in Association with Reducing O6-methylguanine DNA Adduct in A/J Mice

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Prevention Research

• Publication date

  2014-01-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1158/1940-6207.CAPR-13-0301PMID 24403291PMCID PMC3888881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disclosure of Potential Conflicts of Interest

  2014cited by this paper
• Analysis and interpretation of data

  2014cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• Kava in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study

  2013cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Formation and repair of pyridyloxobutyl DNA adducts and their relationship to tumor yield in A/J mice.

  2012influential reference
• Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys.

  2012cited by this paper
• Flavokawain B inhibits growth of human squamous carcinoma cells: Involvement of apoptosis and cell cycle dysregulation in vitro and in vivo.

  2012cited by this paper
• Lung tumorigenesis suppressing effects of a commercial kava extract and its selected compounds in A/J mice.

  2011cited by this paper
• Kavalactone pharmacophores for major cellular drug targets.

  2011cited by this paper
• Flavokawain B, a kava chalcone, induces apoptosis via up‐regulation of death‐receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth

  2010cited by this paper
• Flavokawain B, the hepatotoxic constituent from kava root, induces GSH‐sensitive oxidative stress through modulation of IKK/NF‐κB and MAPK signaling pathways

  2010cited by this paper
• Dr. Duke's Phytochemical and Ethnobotanical Databases

  2010cited by this paper
• Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.

  2009cited by this paper
• Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers

  2009cited by this paper
• Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control

  2008cited by this paper
• Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone plus Benzo[a]pyrene–Induced Lung Tumorigenesis in A/J Mice

  2007cited by this paper
• The tobacco epidemic in the United States.

  2007influential reference
• Quantitation of pyridyloxobutyl DNA adducts of tobacco-specific nitrosamines in rat tissue DNA by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry.

  2006cited by this paper
• Quantitative analysis of early chemically-induced pulmonary lesions in mice of varying susceptibilities to lung tumorigenesis.

  2006cited by this paper
• Mass spectrometric analysis of relative levels of pyridyloxobutylation adducts formed in the reaction of DNA with a chemically activated form of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

  2005cited by this paper
• Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.

  2005cited by this paper
• Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients.

  2003cited by this paper
• Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung.

  2001cited by this paper
• The correlation between cancer incidence and kava consumption.

  2000cited by this paper
• Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies

  2000cited by this paper
• The correlation between cancer incidence and kava consumption.

  2000cited by this paper
• Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China.

  1999cited by this paper
• Smoking cessation and mortality trends among 118,000 Californians, 1960-1997.

  1999cited by this paper
• Reduced lung tumorigenesis in human methylguanine DNA--methyltransferase transgenic mice achieved by expression of transgene within the target cell.

  1999cited by this paper
• Dr. Duke's phytochemical and ethnobotanical databases

  1994cited by this paper
• Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone mouse lung tumorigenesis by arylalkynes, mechanism-based inactivators of cytochrome P450.

  1993cited by this paper
• O6-methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung.

  1991cited by this paper
• Quantitation of microsomal alpha-hydroxylation of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

  1991cited by this paper
• Cancer statistics

  1989cited by this paper
• Cancer incidence in the islands of the Pacific.

  1985cited by this paper
• In vivo mutagenesis by O6-methylguanine built into a unique site in a viral genome.

  1984cited by this paper
• Effects of α-deuterium substitution on the mutagenicity of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)1

  1983cited by this paper
• Effects of alpha-deuterium substitution on the mutagenicity of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK).

  1983cited by this paper

• Kavain for health promotion and disease mitigation: Pharmacological promise and therapeutic perspectives

  2026cites this paper
• AB-Free Kava Suppresses Tobacco Smoke-Induced CREB Phosphorylation in the Mouse Cerebellum

  2025cites this paper
• The potential of AB-free kava in enabling tobacco cessation via management of abstinence-related stress and insomnia: study protocol for a randomized clinical trial

  2024cites this paper
• Flavokavains A- and B-Free Kava Enhances Resilience against the Adverse Health Effects of Tobacco Smoke in Mice.

  2024cites this paper
• One-Week Kava Dietary Supplementation Increases Both Urinary N- and O-Glucuronides of NNAL, a Lung Carcinogen Major Metabolite, among Smokers.

  2024cites this paper
• AB-free kava enhances resilience against the adverse health effects of tobacco smoke in mice

  2024cites this paper
• Reducing tobacco-associated lung cancer risk: a study protocol for a randomized clinical trial of AB-free kava

  2023cites this paper
• Diallyl trisulfide inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer via modulating gut microbiota and the PPARγ/NF-κB pathway.

  2023cites this paper
• Opportunities and Challenges of Kava in Lung Cancer Prevention

  2023influential citation
• Kawain Inhibits Urinary Bladder Carcinogenesis through Epigenetic Inhibition of LSD1 and Upregulation of H3K4 Methylation

  2023influential citation
• Kavalactone Kawain Impedes Urothelial Tumorigenesis in UPII-Mutant Ha-Ras Mice via Inhibition of mTOR Signaling and Alteration of Cancer Metabolism

  2023cites this paper
• Dietary Phytochemicals as Potential Chemopreventive Agents against Tobacco-Induced Lung Carcinogenesis

  2023cites this paper
• In vitro inhibition of carboxylesterase 1 by Kava (Piper methysticum) Kavalactones.

  2022cites this paper
• In vivo Structure‐Activity Relationship of Dihydromethysticin in Reducing Nicotine‐Derived Nitrosamine Ketone (NNK)‐Induced Lung DNA Damage against Lung Carcinogenesis in A/J Mice

  2022cites this paper
• An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava

  2022cites this paper
• Clinical pharmacokinetics of kavalactones after oral dosing of standardized kava extract in healthy volunteers.

  2022cites this paper
• Characterization of different forms of kava (Piper methysticum) products by UPLC-MS/MS

  2021cites this paper
• Exposure to a mixture of cigarette smoke carcinogens disturbs gut microbiota and influences metabolic homeostasis in A/J mice.

  2021cites this paper
• Kava root extracts hinder prostate cancer development and tumorigenesis by involvement of dual inhibition of MAO-A and LSD1

  2021cites this paper
• Garlic oil blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis by inducing phase II drug-metabolizing enzymes.

  2021cites this paper
• Characterization of adductomic totality of NNK, (R)-NNAL, and (S)-NNAL in A/J mice, and their correlations with distinct lung carcinogenicity.

  2021cites this paper
• Oral dosing of dihydromethysticin ahead of tobacco carcinogen NNK effectively prevents lung tumorigenesis in A/J mice.

  2020cites this paper
• The Impact of One-week Dietary Supplementation with Kava on Biomarkers of Tobacco Use and Nitrosamine-based Carcinogenesis Risk among Active Smokers

  2020cites this paper
• Kava as a Clinical Nutrient: Promises and Challenges

  2020cites this paper
• Analysis of methyl DNA adducts and metabolites in BEAS-2B cells induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

  2019cites this paper
• Kava and its Kavalactones Inhibit Norepinephrine-induced Intracellular Calcium Influx in Lung Cancer Cells

  2019influential citation
• A stable isotope dilution tandem mass spectrometry method of major kavalactones and its applications

  2018cites this paper
• A Behavioral Survey of the Effects of Kavalactones on Caenorhabditis elegans Neuromuscular Transmission

  2017cites this paper
• Pilot in Vivo Structure-Activity Relationship of Dihydromethysticin in Blocking 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-Induced O6-Methylguanine and Lung Tumor in A/J Mice.

  2017cites this paper
• UPDATES AND ADDITIONS for Herbal Contraindications &Drug Interactions plus Herbal Adjuncts with Medicines

  2016cites this paper
• Dihydromethysticin (DHM) Blocks Tobacco Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-Induced O6-Methylguanine in a Manner Independent of the Aryl Hydrocarbon Receptor (AhR) Pathway in C57BL/6 Female Mice.

  2016cites this paper
• Contemporary Pacific and Western perspectives on `awa (Piper methysticum) toxicology.

  2015cites this paper
• Flavokawains A and B in Kava, Not Dihydromethysticin, Potentiate Acetaminophen-Induced Hepatotoxicity in C57BL/6 Mice

  2014cites this paper
• Dihydromethysticin from kava blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis and differentially reduces DNA damage in A/J mice.

  2014influential citation
• Measuring the Chemical and Cytotoxic Variability of Commercially Available Kava (Piper methysticum G. Forster)

  2014cites this paper